Health Statement

This page explains, in plain terms, the health-related nature of NeuroTrace, what its results mean and do not mean, and the clinical sources it is built on. It supplements our Privacy Policy and Terms of Service.

NeuroTrace is an educational self-screening checklist and symptom log. It is not:

• a medical device, and it is not registered, certified or approved as one by any regulator (including under EU MDR, US FDA or UK MDR frameworks)
• capable of diagnosing ADHD or any other condition
• a clinical evaluation, treatment, therapy or prescription
• a substitute for professional medical advice, diagnosis or care

The app deliberately avoids diagnostic language. Its output is described as trait consistency — how your self-reported frequency of experiences compares with thresholds in a published screening instrument — never as a diagnosis.

A screening score can only suggest whether your experiences are consistent with traits worth discussing with a professional. Many conditions and everyday circumstances (stress, sleep deprivation, anxiety and more) can produce similar experiences. Only a qualified healthcare professional — such as a psychiatrist, psychologist or physician — can properly assess whether you have ADHD.

If your results concern you, print the app's summary report and bring it to a licensed professional. That report is intended as a conversation aid for a clinical visit, not as evidence of any condition.

The screening questionnaire used in NeuroTrace is a faithful digital implementation of the World Health Organization Composite International Diagnostic Interview's Adult ADHD Self-Report Scale Symptom Checklist (ASRS v1.1):

• Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine. 2005;35(2):245–256.
• Adler LA, Kessler RC, Spencer T. Adult ADHD Self-Report Scale-v1.1 (ASRS-v1.1) Symptom Checklist — instructions and six-question screener, World Health Organization.

Part A scoring follows the published threshold rule: items are counted as "screening positive" when answered at or above their designated frequency, with four or more of six shaded boxes indicating symptoms consistent with Adult ADHD and the need for further evaluation by a clinician. Subscale breakdowns group items into attention and activity/impulsivity domains for discussion purposes only.

The World Health Organization is not affiliated with, and does not sponsor or endorse, NeuroTrace.

Because the app deals with sensitive self-reflections about your own wellbeing, we designed it so that none of that content ever leaves your device: no accounts, no analytics on your answers, no cloud storage. See our Privacy Policy for the complete picture.

NeuroTrace must not be relied upon in emergencies. If you are in crisis, contact your local emergency number or an urgent care or crisis service immediately.

Questions about this statement or the sources we cite? Email kinzinzombe07@gmail.com.